← The Wire
RIGLNasdaq
RIGEL PHARMACEUTICALS INC
Pharmaceutical Preparations · DE · CIK 1034842
Develops and provides novel therapies for hematologic disorders and cancer by targeting critical disease signaling pathways
red 8-K · 90d
$608M
Market cap
$39.04
Last close
+0.9%
1D
+9.3%
5D
284K
Volume
Price · last 39 sessions+32.2%
May 4L $26.04 · H $39.04Jun 29
355
Total filings
Jun 17, 2026
Last filing
12/31
Fiscal year end
DEFA14ADEFA14AApr 3, 2026DEFA14ADEFA14AApr 10, 2025DEFA14AFORM DEFA14AApr 10, 2024DEFA14AFORM DEFA14AApr 14, 2023DEFA14AFORM DEFA14AApr 5, 2022DEFA14ADEFA14AMay 1, 2020DEFA14ADEFA14AApr 1, 2020DEFA14ADEFA14AApr 9, 2019DEFA14ADEFA14AApr 4, 2018DEFA14ADEFA14AMar 29, 2017DEFA14ADEFA14AMay 3, 2016DEFA14ADEFA14AMar 28, 2016DEFA14ADEFA14AMar 30, 2015DEFA14ADEFA14AApr 8, 2014DEFA14ADEFA14AApr 3, 2013DEFA14ADEFA14AApr 12, 2012DEFA14ADEFA14AApr 4, 2011DEFA14ADEFA14AApr 12, 2010DEFA14ADEFA14AApr 15, 2009
Insider Activity
In the 90 days to Feb 20, 2026: 1 sold $145K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 20, 2026 | Moos Walter HDirector | Sell | 4,000 | $36.36 | $145K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance